Status: Recruiting
Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity
The main objective of this study is to demonstrate the superior efficacy of HRS-7535 in controlling blood pressure compared to placebo in subjects with hypertension and overweight or obesity;
Participants needed: 648
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Shandong Suncadia Medicine Co., Ltd.Updated: Jun 5, 2026Locations: 2
Eligibility criteria
On the day of signing the informed consent form, the age should be between 18 an... [+3]
Having a known secondary cause of hypertension [+4]